Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1350, 2011-01, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Adalimumab/infliximab: Psoriasis treated with ustekinumab: case report
Reactions Weekly, Vol. 1, Iss. 1383, 2012-01 ,pp. :
Access to resources
Recommend
Adalimumab/infliximab: Psoriasis: 4 case reports
Reactions Weekly, Vol. 1, Iss. 1198, 2008-01 ,pp. :
Adalimumab/infliximab: Psoriasis: 3 case reports
Reactions Weekly, Vol. 1, Iss. 1128, 2006-01 ,pp. :
Adalimumab/infliximab: First report of pseudolymphoma: case report
Reactions Weekly, Vol. 1, Iss. 1401, 2012-01 ,pp. :